Status:
UNKNOWN
Screening for Early Detection and Prevention of Pompe Disease in Israel Using Tandem Mass Spectrometry
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Pompe Disease
Eligibility:
All Genders
2-7 years
Brief Summary
The aim of the study is: to develop a comprehensive biochemical assay for detection of Pompe disease (glycogen storage disease type II), to be implemented in the Newborn screening program among the I...
Eligibility Criteria
Inclusion
- New born babies born during the study period
Exclusion
- Premature babies
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT01409486
Start Date
September 1 2011
End Date
September 1 2013
Last Update
August 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 31096